Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

TAK-875

TAK-875 50 mg tablets

DRUG

TAK-875 Placebo

TAK-875 placebo-matching tablets

DRUG

Glimepiride

Glimepiride tablet.

Trial Locations (69)

Unknown

Muscle Shoals

Phoenix

Fresno

Long Beach

National City

North Hollywood

Pismo Beach

Lakewood

Boynton Beach

Bradenton

Coral Gables

Miami

North Miami Beach

Orlando

Pembroke Pines

Tampa

Augusta

Conyers

Chicago

Lexington

Oxon Hill

Flint

Omaha

Las Vegas

Nashua

Haddon Heights

Rosedale

Morehead City

Morganton

Maumee

Hanleysville

Uniontown

Laurens

Houston

San Antonio

Spring

Tomball

Manassas

Gabrovo

Plovdiv

Sofia

Oakville

Thornhill

Toronto

Budapest

Gödöllő

Kistelek

Komárom

Zalaegerszeg

Bialystok

Gdansk

Grodzisk Mazowiecki

Kamieniec Ząbkowicki

Lodz

Oświęcim

Poznan

Puławy

Rzeszów

Zgierz

Baia Mare

Ploieşti

Timișoara

Banská Bystrica

Bratislava

Dolný Kubín

Levice

Lučenec

Pezinok

Svidník

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY